Alexander Doyle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexander Doyle has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Kan Ding
Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-8508, USA
4 shared publications - Ghazala Perven
Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
3 shared publications - Hina Dave
Ochsner Medical Center, New Orleans, LA, USA
3 shared publications - Irina Podkorytova
Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
3 shared publications - Jay Harvey
Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, USA
3 shared publications - Mark Agostini
UT Southwestern Med Sch, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
3 shared publications
Latest Publications
- 21 September 2022
- Published by Elsevier in Epilepsy & Behavior
- Vol. 136, 108909
Effects of psychiatric comorbidities in persons with epilepsy on recurrent emergency department visits
- 21 September 2022
- Published by Elsevier in Epilepsy & Behavior
- Vol. 136, 108909
Effects of psychiatric comorbidities in persons with epilepsy on recurrent emergency department visits
- 1 September 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 122, 108225
Emergency department visits and readmissions in patients with psychogenic nonepileptic seizures (PNES) at a safety net hospital
- 1 September 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 122, 108225
Emergency department visits and readmissions in patients with psychogenic nonepileptic seizures (PNES) at a safety net hospital
- 3 April 2021
- Published by Taylor & Francis in The Neurodiagnostic Journal
- Vol. 61 (2) , 95-103
Emergent Admissions to the Epilepsy Monitoring Unit in the Setting of COVID-19 Pandemic-related, State-mandated Restrictions: Clinical Decision Making and Outcomes
Due to the coronavirus disease 2019 (COVID-19) pandemic, the state of Texas-limited elective procedures to conserve beds and personal protective equipment (PPE); therefore, between March 22 and May 18, 2020, admission to the epilepsy monitoring unit (EMU) was limited only to urgent and emergent cases. We evaluated clinical characteristics and outcomes of these patients who were admitted to the EMU. Nineteen patients were admitted (one patient twice) with average age of 36.26 years (11 female) and average length of stay 3 days (range: 2–9 days). At least one event was captured on continuous EEG (cEEG) and video monitoring in all 20 admissions (atypical in one). One patient had both epileptic (ES) and psychogenic non-epileptic seizures (PNES) while 10 had PNES and 9 had ES. In 8 of 9 patients with ES, medications were changed, while in 5 patients with PNES, anti-epileptic drugs (AED) were stopped; the remaining 5 were not on medications. Of the 14 patients who had seen an epileptologist pre-admission, 13 (or 93%) had their diagnosis confirmed by EMU stay; a statistically significant finding. While typically an elective admission, in the setting of the COVID-19 pandemic, urgent and emergent EMU admissions were required for increased seizure or event frequency. In the vast majority of patients (13 of 19), admission lead to medication changes to either better control seizures or to change therapeutics as appropriate when PNES was identified.
- 3 April 2021
- Published by Taylor & Francis in The Neurodiagnostic Journal
- Vol. 61 (2) , 95-103
Emergent Admissions to the Epilepsy Monitoring Unit in the Setting of COVID-19 Pandemic-related, State-mandated Restrictions: Clinical Decision Making and Outcomes
Due to the coronavirus disease 2019 (COVID-19) pandemic, the state of Texas-limited elective procedures to conserve beds and personal protective equipment (PPE); therefore, between March 22 and May 18, 2020, admission to the epilepsy monitoring unit (EMU) was limited only to urgent and emergent cases. We evaluated clinical characteristics and outcomes of these patients who were admitted to the EMU. Nineteen patients were admitted (one patient twice) with average age of 36.26 years (11 female) and average length of stay 3 days (range: 2–9 days). At least one event was captured on continuous EEG (cEEG) and video monitoring in all 20 admissions (atypical in one). One patient had both epileptic (ES) and psychogenic non-epileptic seizures (PNES) while 10 had PNES and 9 had ES. In 8 of 9 patients with ES, medications were changed, while in 5 patients with PNES, anti-epileptic drugs (AED) were stopped; the remaining 5 were not on medications. Of the 14 patients who had seen an epileptologist pre-admission, 13 (or 93%) had their diagnosis confirmed by EMU stay; a statistically significant finding. While typically an elective admission, in the setting of the COVID-19 pandemic, urgent and emergent EMU admissions were required for increased seizure or event frequency. In the vast majority of patients (13 of 19), admission lead to medication changes to either better control seizures or to change therapeutics as appropriate when PNES was identified.
- Open Access
- 1 January 2021
- Published by Elsevier in Epilepsy & Behavior Reports
- Vol. 15, 100441
Non-lesional mesial temporal lobe epilepsy requires bilateral invasive evaluation
- 1 January 2021
- Published by Elsevier in Epilepsy & Behavior Reports
- Vol. 15, 100441
Open AccessNon-lesional mesial temporal lobe epilepsy requires bilateral invasive evaluation